Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol

被引:4
|
作者
Jerene, Degu [1 ]
Levy, Jens [1 ]
van Kalmthout, Kristian [1 ]
Rest, Job van [1 ]
McQuaid, Christopher Finn [2 ]
Quaife, Matthew [2 ]
Charalambous, Salome [3 ]
Gamazina, Katya [4 ]
Garfin, A. M. Celina [5 ]
Mleoh, Liberate [6 ]
Terleieva, Yana [7 ]
Bogdanov, Alexsey [4 ]
Maraba, Noriah [3 ]
Fielding, Katherine [2 ]
机构
[1] KNCV TB Fdn, Div TB Eliminat & Hlth Syst Strengthening, The Hague, Netherlands
[2] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, TB Ctr, Dept Infect Dis Epidemiol, London, England
[3] Aurum Inst, Johannesburg, South Africa
[4] Program Appropriate Technol Hlth, Kiev, Ukraine
[5] Dis Prevent & Control Bur, Dept Hlth, Infect Dis Prevent & Control Div, Manila, Philippines
[6] Dept Prevent Serv, Natl TB & Leprosy Programme, Dodoma, Tanzania
[7] Dept Coordinat TB Treatment Programs, Kiev, Ukraine
来源
BMJ OPEN | 2023年 / 13卷 / 03期
关键词
Tuberculosis; Public health; Tropical medicine; Epidemiology;
D O I
10.1136/bmjopen-2022-068685
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Successful treatment of tuberculosis depends to a large extent on good adherence to treatment regimens, which relies on directly observed treatment (DOT). This in turn requires frequent visits to health facilities. High costs to patients, stigma and burden to the health system challenged the DOT approach. Digital adherence technologies (DATs) have emerged as possibly more feasible alternatives to DOT but there is conflicting evidence on their effectiveness and feasibility. Our primary objective is to evaluate whether the implementation of DATs with daily monitoring and a differentiated response to patient adherence would reduce poor treatment outcomes compared with the standard of care (SOC). Our secondary objectives include: to evaluate the proportion of patients lost to follow-up; to compare effectiveness by DAT type; to evaluate the feasibility and acceptability of DATs; to describe factors affecting the longitudinal engagement of patients with the intervention and to use a simple model to estimate the epidemiological impact and cost-effectiveness of the intervention from a health system perspective.Methods and analysis This is a pragmatic two-arm cluster-randomised trial in the Philippines, South Africa, Tanzania and Ukraine, with health facilities as the unit of randomisation. Facilities will first be randomised to either the DAT or SOC arm, and then the DAT arm will be further randomised into medication sleeve/labels or smart pill box in a 1:1:2 ratio for the smart pill box, medication sleeve/label or the SOC respectively. We will use data from the digital adherence platform and routine health facility records for analysis. In the main analysis, we will employ an intention-to-treat approach to evaluate treatment outcomes.Ethics and dissemination The study has been approved by the WHO Research Ethics Review Committee (0003296), and by country-specific committees. The results will be shared at national and international meetings and will be published in peer-reviewed journals.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial
    Liu, Xiaoqiu
    Thompson, Jennifer
    Dong, Haiyan
    Sweeney, Sedona
    Li, Xue
    Yuan, Yanli
    Wang, Xiaomeng
    He, Wangrui
    Thomas, Bruce
    Xu, Caihong
    Hu, Dongmei
    Vassall, Anna
    Huan, Shitong
    Zhang, Hui
    Jiang, Shiwen
    Fielding, Katherine
    Zhao, Yanlin
    [J]. LANCET GLOBAL HEALTH, 2023, 11 (05): : e693 - e703
  • [2] Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial
    Amare W. Tadesse
    Zemedu Mohammed
    Nicola Foster
    Matthew Quaife
    Christopher Finn McQuaid
    Jens Levy
    Kristian van Kalmthout
    Job van Rest
    Degu Jerene
    Tofik Abdurhman
    Hiwot Yazew
    Demekech G. Umeta
    Demelash Assefa
    Gedion T. Weldemichael
    Ahmed Bedru
    Taye Letta
    Katherine L. Fielding
    [J]. BMC Infectious Diseases, 21
  • [3] Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial
    Tadesse, Amare W.
    Mohammed, Zemedu
    Foster, Nicola
    Quaife, Matthew
    McQuaid, Christopher Finn
    Levy, Jens
    van Kalmthout, Kristian
    van Rest, Job
    Jerene, Degu
    Abdurhman, Tofik
    Yazew, Hiwot
    Umeta, Demekech G.
    Assefa, Demelash
    Weldemichael, Gedion T.
    Bedru, Ahmed
    Letta, Taye
    Fielding, Katherine L.
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [4] Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion
    Crowder, Rebecca
    Kityamuwesi, Alex
    Kiwanuka, Noah
    Lamunu, Maureen
    Namale, Catherine
    Tinka, Lynn Kunihira
    Nakate, Agnes Sanyu
    Ggita, Joseph
    Turimumahoro, Patricia
    Babirye, Diana
    Oyuku, Denis
    Berger, Christopher Allen
    Tucker, Austin
    Patel, Devika
    Sammann, Amanda
    Dowdy, David
    Stavia, Turyahabwe
    Cattamanchi, Adithya
    Katamba, Achilles
    [J]. BMJ OPEN, 2020, 10 (11):
  • [5] Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial
    Nicola Foster
    Amare W. Tadesse
    Christopher Finn McQuaid
    Lara Gosce
    Tofik Abdurhman
    Demelash Assefa
    Ahmed Bedru
    Rein M. G. J. Houben
    Kristian van Kalmthout
    Taye Letta
    Zemedu Mohammed
    Job van Rest
    Demekech G. Umeta
    Gedion T. Weldemichael
    Hiwot Yazew
    Degu Jerene
    Matthew Quaife
    Katherine L. Fielding
    [J]. Trials, 24
  • [6] Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial
    Foster, Nicola
    Tadesse, Amare W.
    McQuaid, Christopher Finn
    Gosce, Lara
    Abdurhman, Tofik
    Assefa, Demelash
    Bedru, Ahmed
    Houben, Rein M. G. J.
    van Kalmthout, Kristian
    Letta, Taye
    Mohammed, Zemedu
    van Rest, Job
    Umeta, Demekech G.
    Weldemichael, Gedion T.
    Yazew, Hiwot
    Jerene, Degu
    Quaife, Matthew
    Fielding, Katherine L.
    [J]. TRIALS, 2023, 24 (01)
  • [7] Can digital adherence technologies reduce inequity in tuberculosis treatment success? Evidence from a randomised controlled trial
    Boutilier, Justin J.
    Yoeli, Erez
    Rathauser, Jon
    Owiti, Philip
    Subbaraman, Ramnath
    Jonasson, Jonas Oddur
    [J]. BMJ GLOBAL HEALTH, 2022, 7 (12):
  • [8] Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients’ treatment adherence via electronic monitors and an app versus usual care in Tibet
    Xiaolin Wei
    Joseph Paul Hicks
    Pande Pasang
    Zhitong Zhang
    Victoria Haldane
    Xiaoqiu Liu
    Tingting Yin
    Lixia Wang
    Dachun Shi
    Shiliang Ge
    John Walley
    Ross Upshur
    Jun Hu
    [J]. Trials, 20
  • [9] Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients' treatment adherence via electronic monitors and an app versus usual care in Tibet
    Wei, Xiaolin
    Hicks, Joseph Paul
    Pasang, Pande
    Zhang, Zhitong
    Haldane, Victoria
    Liu, Xiaoqiu
    Yin, Tingting
    Wang, Lixia
    Shi, Dachun
    Ge, Shiliang
    Walley, John
    Upshur, Ross
    Hu, Jun
    [J]. TRIALS, 2019, 20 (1)
  • [10] Protocol for a pragmatic cluster randomised controlled trial to evaluate the effectiveness of digital health interventions in improving non-communicable disease management during the pandemic in rural Pakistan
    Wei, Xiaolin
    Khan, Nida
    Durrani, Hammad
    Muzaffar, Naila
    Haldane, Victoria
    Walley, John D.
    Thorpe, Kevin
    Ge, Erjia
    Ge, Shiliang
    Dodd, Warren
    Wallace, James
    Aslanyan, Garry
    Laporte, Audrey
    Khan, Muhammad Amir
    [J]. PLOS ONE, 2023, 18 (10):